Zoltan Nagy
Professor of Chemical Engineering, Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN, USA
In the field of pharmaceutical manufacturing, traditional small molecules and complex biologics coexist with novel therapeutic modalities that offer extremely valuable treatments for patients. Molecular complexity of drug substances, drug product presentations, and development cycle times have significantly shifted as a result of the global COVID-19 pandemic. The major engine behind these changes is the adoption of advanced manufacturing and processing platforms. Efficiency, agility, and flexibility are the key drivers.
In this session, subject matter experts from industry, academia and government will discuss major innovations, drivers, and barriers.
